Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalassemia and abnormal hemoglobin.

Suthat Fucharoen1, Pranee Winichagoon

  • 1Thalassemia Research Center, Institue of Science and Technology for Research and Development, Mahidol University, Nakornpathom, Thailand.

International Journal of Hematology
|November 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutrophil extracellular traps induced by activated platelets as a cause of neutrophil-platelet aggregation in β-thalassaemia/haemoglobin E patients.

British journal of haematology·2026
Same author

Beyond iron deficiency: A comprehensive national survey of anaemia etiology in Sri Lankan young adults.

Scientific reports·2026
Same author

Enhanced induction of fetal hemoglobin by the combination of decitabine with RN-1 in β-thalassemia/HbE erythroid progenitor cells.

Molecular medicine (Cambridge, Mass.)·2026
Same author

An In-Depth Analysis of Variable Dynamics Influencing Bone Mineral Density in Transfusion-Dependent Thalassemia Patients.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2025
Same author

Extracellular vesicles modulate endothelial nitric oxide production in patients with β‑thalassaemia/HbE.

Biomedical reports·2025
Same author

Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals.

Scientific reports·2024
Same journal

Cytarabine-based induction and oral maintenance therapy for a single system with single-site Langerhans cell histiocytosis.

International journal of hematology·2026
Same journal

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.

International journal of hematology·2026
Same journal

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

International journal of hematology·2026
Same journal

The efficacy of prophylactic tranexamic acid in patients with hematologic malignancy: a systematic review and meta-analysis.

International journal of hematology·2026
Same journal

Current status and challenges of TCR-T cell therapy for AML/MDS.

International journal of hematology·2026
Same journal

Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study.

International journal of hematology·2026
See all related articles

Thalassemia and abnormal hemoglobins are prevalent genetic disorders in Asia. Simple screening tests and advanced HPLC systems aid in identifying carriers, but DNA analysis is crucial for precise mutation detection and understanding disease variability.

Area of Science:

  • Medical Genetics
  • Hematology
  • Public Health

Background:

  • Thalassemia and abnormal hemoglobins represent significant genetic health and socioeconomic challenges in Asia.
  • Preventing new cases necessitates accurate identification of at-risk couples, but current diagnostic methods are often impractical for large-scale screening.

Purpose of the Study:

  • To evaluate simple laboratory tests and automated HPLC for screening thalassemia carriers.
  • To explore advanced DNA analysis techniques, including DNA chip technology, for specific mutation detection.
  • To investigate factors contributing to the clinical heterogeneity of beta-thalassemia.

Main Methods:

  • Screening using two simple laboratory tests.
  • Automated High-Performance Liquid Chromatography (HPLC) for qualitative and quantitative hemoglobin analysis.

Related Experiment Videos

  • DNA analysis techniques, including DNA chip technology, for mutation detection.

    • Main Results:

    • Simple tests and automated HPLC offer rapid screening for thalassemia carriers and hemoglobin E.
    • HPLC provides precise and reproducible hemoglobin component analysis for prenatal and postnatal diagnosis.
    • DNA analysis is essential for specific genotype diagnosis, with DNA chips showing promise for mutation detection.

    Conclusions:

    • Current screening methods are effective for identifying potential carriers but lack specificity for genotypic diagnosis.
    • Automated HPLC and DNA analysis, including emerging DNA chip technology, are vital tools for thalassemia diagnosis and management.
    • Clinical variability in beta-thalassemia suggests the influence of additional genetic or environmental factors beyond known mutations and interactions.